Design Therapeutics

DSGNNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$875.517 M

$13.99 +1.60%

Close of 7 Aug 2026

Revenue

$0.00

#3658 by revenue

Earnings

-$69.8M

Loss-making

Shares outstanding

62,581,651

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#170Arbutus BiopharmaABUS$914.6M
#171AnnexonANNX$886.4M
#172Design TherapeuticsDSGN$875.5M
#173Theravance BiopharmaTBPH$872.8M
#174Kura OncologyKURA$849.6M

Where these numbers come from

Share counts and financials for Design Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.